Literature DB >> 20467734

Radiological findings of community-acquired methicillin-resistant and methicillin-susceptible Staphylococcus aureus pediatric pneumonia in Hawaii.

Guliz Erdem1, Lora Bergert, Kyra Len, Marian Melish, Kevin Kon, Robert DiMauro.   

Abstract

BACKGROUND: Community-acquired Staphylococcus aureus (CA-SA) infections are common among pediatric patients in Hawaii.
OBJECTIVE: We wanted to characterize the radiological features of methicillin-susceptible (CA-MSSA) and methicillin-resistant (CA-MRSA) staphylococcal pneumonia in Hawaiian children.
MATERIALS AND METHODS: We retrospectively reviewed medical records and imaging studies of children with SA pneumonia identified from 1996 through 2007.
RESULTS: Of 40 children, 26 (65%) had CA-MRSA pneumonia and 14 patients (35%) had CA-MSSA pneumonia. CA-MRSA patients were significantly younger than CA-MSSA patients (65% younger than 1 year vs. 36% older). In a majority (62%) of CA-MRSA patients, the consolidation was unilateral; in most of the CA-MSSA cases (79%), the consolidation was bilateral. Fifty percent of the patients with CA-MRSA and 21% of those with CA-MSSA had pneumatoceles (P = 0.1). CA-MRSA patients more commonly had pleural effusions (85% vs. 64% for CA-MSSA) and pleural thickening (50% vs. 36% for CA-MSSA).
CONCLUSION: This case series describes the radiologic characteristics of CA-MRSA and CA-MSSA pneumonia in children in a highly endemic area. We found that CA-MRSA pneumonias are unilateral in a majority of pediatric pneumonia cases, are more common in children 1 year or younger, and have higher rates of complications in comparison to CA-MSSA patients.

Entities:  

Mesh:

Year:  2010        PMID: 20467734     DOI: 10.1007/s00247-010-1680-0

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  34 in total

1.  Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes.

Authors:  John S Francis; Meg C Doherty; Uri Lopatin; Cecilia P Johnston; Gita Sinha; Tracy Ross; Mian Cai; Nadia N Hansel; Trish Perl; John R Ticehurst; Karen Carroll; David L Thomas; Eric Nuermberger; John G Bartlett
Journal:  Clin Infect Dis       Date:  2004-12-07       Impact factor: 9.079

2.  Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients.

Authors:  Yves Gillet; Bertrand Issartel; Philippe Vanhems; Jean-Christophe Fournet; Gerard Lina; Michèle Bes; François Vandenesch; Yves Piémont; Nicole Brousse; Daniel Floret; Jerome Etienne
Journal:  Lancet       Date:  2002-03-02       Impact factor: 79.321

3.  Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk.

Authors:  B C Herold; L C Immergluck; M C Maranan; D S Lauderdale; R E Gaskin; S Boyle-Vavra; C D Leitch; R S Daum
Journal:  JAMA       Date:  1998-02-25       Impact factor: 56.272

Review 4.  Increasing occurrence of methicillin-resistant Staphylococcus aureus in the United States.

Authors:  J M Boyce; W A Causey
Journal:  Infect Control       Date:  1982 Sep-Oct

5.  Emergence of community-associated methicillin resistant Staphylococcus aureus in Hawaii, 2001-2003.

Authors:  Concepcion F Estivariz; Sarah Y Park; Jeffrey C Hageman; Jeffrey Dvorin; Marian M Melish; Rose Arpon; Pat Coon; Susan Slavish; Mary Kim; Linda K McDougal; Bette Jensen; Sigrid McAllister; David Lonsway; George Killgore; Paul E Effler; Daniel B Jernigan
Journal:  J Infect       Date:  2006-09-20       Impact factor: 6.072

6.  Severe methicillin-resistant Staphylococcus aureus community-acquired pneumonia associated with influenza--Louisiana and Georgia, December 2006-January 2007.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2007-04-13       Impact factor: 17.586

7.  Comparison of mortality risk associated with bacteremia due to methicillin-resistant and methicillin-susceptible Staphylococcus aureus.

Authors:  Simone Shurland; Min Zhan; Douglas D Bradham; Mary-Claire Roghmann
Journal:  Infect Control Hosp Epidemiol       Date:  2007-02-15       Impact factor: 3.254

8.  Predicting methicillin resistance and the effect of inadequate empiric therapy on survival in patients with Staphylococcus aureus bacteremia.

Authors:  M C Roghmann
Journal:  Arch Intern Med       Date:  2000-04-10

9.  Panton-Valentine leukocidin is not a virulence determinant in murine models of community-associated methicillin-resistant Staphylococcus aureus disease.

Authors:  Juliane Bubeck Wardenburg; Amy M Palazzolo-Ballance; Michael Otto; Olaf Schneewind; Frank R DeLeo
Journal:  J Infect Dis       Date:  2008-10-15       Impact factor: 5.226

10.  Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-04 influenza season.

Authors:  Jeffrey C Hageman; Timothy M Uyeki; John S Francis; Daniel B Jernigan; J Gary Wheeler; Carolyn B Bridges; Stephen J Barenkamp; Dawn M Sievert; Arjun Srinivasan; Meg C Doherty; Linda K McDougal; George E Killgore; Uri A Lopatin; Rebecca Coffman; J Kathryn MacDonald; Sigrid K McAllister; Gregory E Fosheim; Jean B Patel; L Clifford McDonald
Journal:  Emerg Infect Dis       Date:  2006-06       Impact factor: 6.883

View more
  3 in total

Review 1.  Diffuse Cystic Lung Disease. Part I.

Authors:  Nishant Gupta; Robert Vassallo; Kathryn A Wikenheiser-Brokamp; Francis X McCormack
Journal:  Am J Respir Crit Care Med       Date:  2015-06-15       Impact factor: 21.405

2.  Asthma and pneumonia among children less than five years with acute respiratory symptoms in Mulago Hospital, Uganda: evidence of under-diagnosis of asthma.

Authors:  Rebecca Nantanda; James K Tumwine; Grace Ndeezi; Marianne S Ostergaard
Journal:  PLoS One       Date:  2013-11-29       Impact factor: 3.240

3.  Clinical outcomes of children with acute asthma and pneumonia in Mulago hospital, Uganda: a prospective study.

Authors:  Rebecca Nantanda; Marianne S Ostergaard; Grace Ndeezi; James K Tumwine
Journal:  BMC Pediatr       Date:  2014-11-28       Impact factor: 2.125

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.